Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

UK consortium targets 1,500 ventilators per week in race against time

Published 02/04/2020, 10:48
Updated 02/04/2020, 13:40
© Reuters.

By Kate Holton and Costas Pitas

LONDON (Reuters) - A consortium of aerospace, Formula One and engineering firms hopes soon to be making at least 1,500 ventilators a week as Britain races to boost the number of devices which can help save the lives of those with coronavirus.

Countries need more ventilators, mechanical breathing devices that can blow air and oxygen into the lungs, which aid people suffering from lung failure, one of the complications of severe COVID-19, the disease caused by the pandemic.

Britain has ordered more than 10,000 of them from a group including Ford, Airbus and McLaren but on Wednesday a government spokesman said the first batch would be "up to 30", prompting criticism that the level was too low.

"It is vital that we balance the twin imperatives of speed of delivery with the absolute adherence to regulatory standards that is needed to ensure patient safety," said Dick Elsy, the chief executive of the High Value Manufacturing Catapult, which is leading the project.

"We are targeting production of at least 1,500 units a week of the Penlon and Smiths models combined within a matter of weeks."

The former engineering unit of the Williams (NYSE:WMB) F1 team said on Thursday it will help produce an initial batch of 5,000 ventilators, which forms part of the government order.

Britain's National Health Service has around 8,000 ventilators at its disposal with more being bought from abroad and the potential for thousands to be built domestically, subject to regulatory approval and final deals being struck.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The British Medical Association, which represents doctors, has warned that staff may be faced with difficult decisions over scarce resources.

"Health professionals may be obliged to withdraw treatment from some patients to enable treatment of other patients with a higher survival probability," it said.

Latest comments

The consortium need to ramp up delivery. Ventilators are not difficult products to produce. Don't spend too much re designing product. That can come later after the 1000th delivered, by then the steep learning curve will given manufacturers confidence to re engineer.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.